bioRxiv Science⌕ Search

bioRxiv · 10.64898/2026.09.01.748633

Evaluating the Robustness of Path-Preservation Benchmarks for Dimensionality Reduction Across Point-Density Thresholds: Linear and Cyclic Single-Cell Trajectories

Abstract

Motivation: Comparative studies of trajectory inference (TI) methods evaluate complete computational pipelines, making it impossible to isolate how much distortion is introduced specifically by the dimensionality reduction (DR) step. To our knowledge, no study has directly and systematically evaluated how well DR methods alone preserve a known reference path when projecting high-dimensional single-cell data to two dimensions, and no current study has introduced a dedicated set of metrics to quantify the degree of path-preservation quality after dimensionality reduction. This gap matters because DR is a universal preprocessing choice that shapes all downstream trajectory analysis, yet its independent geometric effect on path structure remains uncharacterized, and practitioners have no principled way to quantify it. Methods: We tested a panel of candidate path-preservation metrics on two single-cell datasets with known reference trajectories, one linear and one cyclic, to determine whether the resulting metric values, DR-method rankings, and overall conclusions are sensitive to the number of points used to construct and display the path, and whether they remain stable once that choice is fixed. The primary linear dataset is a CD4+ T-cell surface-protein dataset (3,096 cells, 51 proteins); a ground-truth reference path was constructed from cells lying close to the first principal component (PC1) of a single cluster, providing a known linear trajectory in the high-dimensional space. Sixteen DR methods were applied and twelve geometric path-preservation metrics were computed, spanning log-ratio distortions of length, curvature, and spatial similarity; Spearman rank correlations of pairwise distances and segment lengths; and structural complexity measures including self-intersection frequency and coiling. To test the sensitivity of this evaluation framework to path density, we varied the fraction of cells used to define the reference path from 1% to 10% (31-310 path points) and tracked how method rankings responded. The same analysis was repeated on a topologically distinct reference, a closed B-cell cell-cycle loop detected by persistent homology in a separate CyTOF dataset, to test whether these conclusions about metric and method stability hold for cyclic as well as linear trajectories. Results: The central sensitivity question, whether the number of points used to construct the reference path changes the evaluation's conclusions, was answered negatively on both datasets. On the linear PC1 trajectory, absolute values of all twelve metrics shifted smoothly as the path-density threshold was varied from 1% to 10% (31-310 points), reflecting the broadening of the reference band, but each method's composite rank remained stable across every threshold: no method changed performance tier as the hyperparameter varied. A composite rank aggregating all twelve metrics identified the same consistently high-performing methods (UMAP, MDS, CNPE, TSNE, SPE, LPMIP) and consistently low-performing methods (SPMDS, LPP, DVE, LAPEIG, PHATE) at every density level tested. Considered on its own, `SpatDistSpear`, the single most discriminating metric, separated a high-fidelity group (LPMIP, DM, MDS, SPMDS, DVE, CISOMAP, CNPE; all r > 0.80) from a mid-range group (LAPEIG, SPE, PHATE, UMAP, TSNE, FOSMOD) and a low-fidelity group (PFA, NNP, LPP); global distance preservation and overall composite performance therefore do not always agree on the same "top tier" of methods, but this disagreement in which metric identifies the best methods is itself density-independent rather than an artifact of the specific threshold chosen. The cyclic loop reproduced the same density-independence: absolute metric values drifted with the per-segment band width, yet each method's composite rank again held constant across all eleven density levels. The identity of the best and worst performers was largely, though not entirely, conserved between the two topologies, with CNPE, LPMIP, SPE, and MDS as top performers and LAPEIG, DVE, and SPMDS as poor performers on both the linear path and the closed loop. UMAP and TSNE were exceptions, dropping from top performers on the linear path to the middle of the sixteen-method panel, rather than the worst tier, on the closed loop. This topology-dependence is a property of the reference geometry rather than of path density: it holds consistently regardless of how many points are used to define the path. Significance: This work introduces a direct, pipeline-independent evaluation of how DR methods distort trajectory geometry, a benchmarking dimension absent from existing TI comparisons. The within-dataset rank stability result, demonstrated on both a linear and a cyclic reference trajectory, validates the use of a fixed reference-path threshold as a robust operating point for large-scale DR benchmarking; however, the partial reordering of top performers between topologies shows that a method's DR benchmark ranking is trajectory-shape-dependent and should not be assumed to transfer from a linear to a cyclic reference.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Bombina, P., Coombes, K. R.. 2026-09-05. Evaluating the Robustness of Path-Preservation Benchmarks for Dimensionality Reduction Across Point-Density Thresholds: Linear and Cyclic Single-Cell Trajectories. https://doi.org/10.64898/2026.09.01.748633

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

A meta-interaction basis for cell-cell communication in tissues

Tissue function depends on signals exchanged between cells and the responses they elicit. Yet whether diverse cell-cell interactions in situ form recurrent sender-receiver programs remains unclear. We present SpiderNet, an interpretable representation-learning framework that discovers such directed programs as a compact basis of cell-cell meta-interactions (MIs) from spatial transcriptomics. SpiderNet jointly learns which sender regulators, ligand-receptor pairs, and receiver targets define each MI and where each program is active across neighboring cell pairs. The resulting representation traces multicellular relays and links communication to cell states, perturbation responses, and phenotypes. SpiderNet recovers ground-truth MIs and their molecular components in simulations and, in real tissues, shows stronger direction-specific agreement with independently curated regulatory programs in senders and receivers than alternative methods. Across more than 5.8 million spatially profiled cells, SpiderNet resolves an SPP1-THBS relay linking monocytes, fibroblasts, and tumor cells within an immune-suppressive ovarian cancer niche, predicts T-cell responses to held-out melanoma-cell perturbations, and identifies a T-cell-associated brain-aging program and age-predictive signals that transfer across regions and platforms. It reveals a recurrent pan-cancer COLLAGEN-linked fibroblast-tumor program whose projected abundance in independent cohorts is associated with poorer survival and non-response to immunotherapy. SpiderNet thus establishes MIs as a reusable organizational layer between molecular interactions and tissue phenotypes, providing a framework to resolve, compare, trace, and perturb multicellular regulation in situ.

bioinformatics↗

Heterogeneous Graph Contrastive Learning for Drug-Gene-Disease Motif Prediction

Drug repurposing and target discovery offer critical strategies for advancing therapeutic development by uncovering the potential biological pathways and novel associations among drugs, genes, and diseases. However, experimental discovery remains expensive and time-consuming, which limits the scalability of large-scale studies. In addition, existing computational approaches often struggle to effectively integrate heterogeneous biomedical data, capture the complex higher-order topological signatures of biological interactomes, and generalize to unseen entities. Here, we present HANAMI (Heterogeneous grAph coNtrastive leArning for drug-gene-disease Motif predIction), a multi-view deep graph learning framework designed to model complex interactions among drugs, genes, and diseases. HANAMI integrates diverse heterogeneous biomedical knowledge, including chemical structures, genomic sequences, and clinical phenotypes, and leverages relation-aware topology encoding, structure-aware aggregation, and contrastive learning to enable accurate motif prediction with biological context from the network. Systematic evaluation on benchmark datasets shows that HANAMI achieves up to 6% improvements over existing state-of-the-art methods in predicting drug-gene-disease motifs. The framework further demonstrates strong inductive generalization, maintaining an [~]18% performance advantage in zero-shot settings involving previously unseen entities. Beyond predictive performance, HANAMI effectively prioritizes drug-disease relationships investigated in Phase II or III trials while identifying candidate genes that suggest plausible mechanistic links. Together, HANAMI provides a computational framework for interpreting complex biomedical interactions, offering a scalable foundation to accelerate drug repurposing and therapeutic innovation.

bioinformatics↗

PTMExplorer: A Multi-Dimensional Integrative Visualization Platform for Protein Post-Translational Modification Function and Structure

Deciphering the functions of post-translational modifications (PTMs) is a critical bridge connecting large-scale modification proteomics data to mechanistic studies. However, most existing tools for visualizing PTM omics data are limited to site catalogs or single-dimensional feature displays. They lack the capability to simultaneously map user-derived differential modification sites onto multi-dimensional contexts, including protein three-dimensional (3D) structure, evolutionary conservation, functional sites, and disease associations. This limitation makes it difficult for researchers to rapidly assess the biological importance of candidate sites from among a vast number of differentially modified sites. Here, we present PTMExplorer, an interactive platform for the multi-dimensional visualization of protein PTMs. PTMExplorer comprises three core modules: PTM Inspector, built upon ProtVista, provides a multi-track, sequence-feature integrated view incorporating intrinsically disordered region (IDR) prediction (via flDPnn), surface accessibility calculation (via FreeSASA), and UniProt functional annotations; PTM 3D Locator, leveraging the Nightingale/Mol* engine, anchors modification sites onto AlphaFold/Protein Data Bank (PDB) 3D structures through residue mapping via PDBe-SIFTS; and PTM Overview, utilizing the R circlize package, presents a panoramic polar circos plot illustrating modification distribution and inter-group differential regulation. Additionally, three major disease-associated modification databases (PTMD, qPTM, and PhosCancer) are integrated as PTM-Disease Nexus, enabling co-localization comparison between user-defined differential sites and reported disease-related sites. PTMExplorer currently supports eight model organisms, accepts user-uploaded differential analysis results, and provides multi-dimensional annotations and various visualization options (https://www.bioladder.cn/PTMExplorer/). Using a multi-omics dataset from hepatocellular carcinoma (18 patients, 9 modification types) as a case study, we demonstrate the practical utility of PTMExplorer in screening potential biomarkers, revealing multi-modification coordination mechanisms, and distinguishing between absolute and relative quantification patterns.

bioinformatics↗